| scholarly article | Q13442814 |
| P2093 | author name string | Hoiby N | |
| P433 | issue | 4 | |
| P921 | main subject | epidemiology | Q133805 |
| cystic fibrosis | Q178194 | ||
| patient | Q181600 | ||
| bacteriology | Q243748 | ||
| P304 | page(s) | 541-550 | |
| P577 | publication date | 1974-08-01 | |
| P1433 | published in | Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology | Q27709655 |
| P1476 | title | Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis | |
| P478 | volume | 82 |
| Q60049204 | Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients |
| Q40207619 | Aeration selects for mucoid phenotype of Pseudomonas aeruginosa. |
| Q34252814 | Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing |
| Q39504806 | Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function |
| Q40620246 | Antimicrobial Susceptibilities of Rough, Smooth, and Mucoid Colony Types of Pseudomonas Isolated from Cystic Fibrosis Patients |
| Q33689754 | Antimicrobial susceptibility of Haemophilus influenzae in the respiratory tracts of patients with cystic fibrosis |
| Q41223323 | Chemoprophylaxis of respiratory infections |
| Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
| Q38007627 | Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management |
| Q37289801 | Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae |
| Q36960820 | Environmental conditions which influence mucoid conversion Pseudomonas aeruginosa PAO1 |
| Q43082590 | Epidemiology of Staphylococcus aureus in patients with cystic fibrosis |
| Q41554427 | Evaluation of long term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease |
| Q39997040 | Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection |
| Q35193295 | First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis |
| Q35827057 | Food as a source for quorum sensing inhibitors: iberin from horseradish revealed as a quorum sensing inhibitor of Pseudomonas aeruginosa |
| Q38921233 | Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis |
| Q37127510 | Haemophilus influenzae is frequently detected with monoclonal antibody 8BD9 in sputum samples from patients with cystic fibrosis |
| Q68354390 | IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA |
| Q37075545 | In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase |
| Q82793585 | In vitro screens for quorum sensing inhibitors and in vivo confirmation of their effect |
| Q34381458 | Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes |
| Q36887970 | OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model |
| Q38818894 | Pneumococcal vaccines for cystic fibrosis. |
| Q33859051 | Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. |
| Q35616635 | Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study |
| Q36520797 | Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa |
| Q34111815 | Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis |
| Q40512604 | Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro |
| Q36732549 | Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. |
| Q33911265 | Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients |
| Q41145157 | Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark |
| Q70399106 | Sputum penetration of fusidic acid in patients with cystic fibrosis |
| Q33825634 | The changing microbial epidemiology in cystic fibrosis |
| Q35987288 | The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications |
| Q39685600 | The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis |
| Q26752460 | Utilization and control of ecological interactions in polymicrobial infections and community-based microbial cell factories |
| Q36536995 | Variation in metabolic enzyme activity of persistent Haemophilus influenzae in respiratory tracts of patients with cystic fibrosis. |
Search more.